InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Earnings radar
Archive

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-26)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

IT IT1,445 companies

IT-Listed Companies

Regulator: Consob.

OPENJOBMETIS INTERNAL DEALING_24 APRILE 2024

OPENJOBMETIS INTERNAL DEALING_28 GIUGNO 2023

OPENJOBMETIS OJM_PR_BOD 29

OPENJOBMETIS OJM_PR_BOD 29

Consumer Cyclical · 2.5m

OPS ECOM APPROVAL OF A STRATEGIC AGREEMENT FOR THE RENTAL OF THE BUSINESS UNIT IN THE TRAVEL RETAIL SECTOR BETWEEN GIGLIO GROUP AND SALOTTO DI BRERA SRL

OPS ECOM GIGLIO GROUP SPA: SHAREHOLDERS' MEETING OF 24 MAY 2023

Consumer Cyclical · 2.5m

OPS ECOM GIGLIO GROUP SPA: SHAREHOLDERS' MEETING OF 24 MAY 2023

← PreviousPage 21 of 29Next →

OPS ECOM GIGLIO GROUP: THE BOARD OF DIRECTORS APPROVES THE RESULTS AS OF 31 DECEMBER 2023

Consumer Cyclical · 2.5m

OPS ECOM INTEGRAZIONI INFORMAZIONI SU ASSEMBLEA ORDINARIA E STRAORDINARIA DI OPS ECOM

OPS ECOM OPS E-COM –

OPS ECOM THE BOARD OF DIRECTORS APPROVES THE INTERIM FINANCIAL REPORTS AS OF 30

Consumer Cyclical · 2.5m

OPS ECOM THE BOARD OF DIRECTORS APPROVES THE INTERIM FINANCIAL REPORTS AS OF 30

OPS Ecom Approval of a Strategic Agreement for the Rental of the Business Unit in the Travel Retail Sector Between Giglio Group and Salotto di Brera SRL

Consumer Cyclical · 2.5m

OPS Ecom Integrazioni Informazioni SU Assemblea Ordinaria e Straordinaria di OPS Ecom

Consumer Cyclical · 2.5m

OPS Ecom OPS e-Com –

Consumer Cyclical · 2.5m

Communication Services · 804k

Agroalimentaire

Agroalimentaire · 255m

OSAI AUTOMATION SYSTEM CS ITAENG OSAI A.S. S.P.A. SB IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2023

OSAI AUTOMATION SYSTEM CS ITAENG OSAI A.S. S.P.A. SB IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2023

Healthcare · 22m

Healthcare · 22m

Openjobmetis Internal Dealing

Santé & Pharma · 520m

PHARMANUTRA AVVISO DI DEPOSITO DELLA LISTA PER LA NOMINA DEL COLLEGIO SINDACALE

PHARMANUTRA CDA DELIBERA DI CONVOCARE L’ASSEMBLEA ORDINARIA E STRAORDINARIA DELLA SOCIETÀ_BOARD OF DIRECTORS CONVENE THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING

Healthcare · 862m

PHARMANUTRA CS - DEPOSITO DEL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2023

PHARMANUTRA CS - DEPOSITO DEL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2023

Healthcare · 862m

PHARMANUTRA CS - PHARMANUTRA - PHN - CETILAR AL FIANCO DI FERNANDO ALONSO

PHARMANUTRA CS PHARMANUTRA - PHN - APPROVAZIONE BILANCIO DI SOSTENIBILITA' 2022

PHARMANUTRA CS PHARMANUTRA - PHN - APPROVAZIONE BILANCIO DI SOSTENIBILITA' 2022

Healthcare · 862m

PHARMANUTRA FIRST HALF 2023 RESULTS

Healthcare · 862m

PHARMANUTRA FIRST HALF 2023 RESULTS

PHARMANUTRA INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023

PHARMANUTRA INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023

Healthcare · 862m

PHARMANUTRA NOTICE OF FILING OF THE LIST FOR THE APPOINTMENT OF THE BOARD OF STATUTORY AUDITORS

PHARMANUTRA PHARMANUTRA

PHARMANUTRA PHARMANUTRA - PHN - DEPOSITO DOCUMENTAZIONE PER ASSEMBLEA DEGLI AZIONISTI

PHARMANUTRA PHARMANUTRA - PHN - ORIENTAMENTI DEL CDA AGLI AZIONISTI SULLA FUTURA DIMENSIONE E COMPOSIZIONE DEL NUOVO CDA - NOMINA DELL’INVESTOR RELATOR

PHARMANUTRA PHARMANUTRA - PHN: IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2025

Healthcare · 862m

PHARMANUTRA PHARMANUTRA - PHN: IL CDA APPROVA IL PROGETTO DI BILANCIO DI ESERCIZIO E IL BILANCIO CONSOLIDATO AL 31 DICEMBRE 2025

PHARMANUTRA PHARMANUTRA - PHN: THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2025

Healthcare · 862m

PHARMANUTRA PHARMANUTRA - PHN: THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2025